RCE

0.97%

52.0¢ recce pharmaceuticals ltd

Cup and handle/ double bottom normally a good thing i believe?...

First 6 Last

Share
Profile

Follow
andrewk65

5,374 Posts.

692

29/05/24

13:43

Post #: 74064018
Share

Originally posted by andrewk65: ↑

I don't know for sure but i can only guess maybe the plan is to get some sort of approval for a product that can be sold in Indo and generate some income.

Regardless of how valuable we may think this approach is. It is fairly evident that the previous big CR amount of around 26 million was drained just achieving in Human safety data and some phase 1 progress. Then another 12 million that looks like it is disappearing quickly too to get to current stage. They desperately need to generate some income from somewhere i would think otherwise further dilution for all including the directors is inevitable.

Seems one can consider this akin to mining with the question "Is it a duster?". We just have to decide do we believe this product can ultimately work or is it some sort of hoax?

For me, there seem to be too many emergency access stories and early trial results to think it doesn't work. It just seems the difficulty is figuring the best application and dose. The difficulty seems to be internal application doesn't quite do what we expected so changes were made. External application also it appears had to be adjusted on the run due to results achieved? Either way it is all progress.

The timelines don't seem unusual for a "Normal" drug development approval path, maybe the incredible fast approvals for covid vaks gave everyone a false sense of how long it takes?

From a chart point of view it is certainly looking IMO like it has finally bottomed out and may be reversing? Could even call it a cup and handle forming now??

Expand

Cup and handle/ double bottom normally a good thing i believe? Especially after a multi year down trend? If it can get back up to around 70c levels and complete the handle it might be on for all?

Last edited by andrewk65: 29/05/24

RCE Price at posting: 59.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 27 more messages in this thread...

First 6 Last

Add RCE (ASX) to my watchlist

(20min delay)
Last 52.0¢		Change 0.005(0.97%)		Mkt cap ! $120.5M

Open	High	Low	Value	Volume
54.0¢	54.0¢	52.0¢	$4.485K	8.497K

Buyers (Bids)

No.	Vol.	Price($)
1	17	52.0¢

Sellers (Offers)

Price($)	Vol.	No.
53.0¢	14897	2

View Market Depth

No.	Vol.	Price($)
2	20282	0.515
1	290	0.510
1	50000	0.505
5	51000	0.500
1	6062	0.495

Price($)	Vol.	No.
0.530	14897	2
0.540	50460	5
0.545	12278	2
0.550	135601	3
0.560	5000	1

Last trade - 15.47pm 04/10/2024 (20 minute delay)

RCE (ASX) Chart

Cup and handle/ double bottom normally a good thing i believe?...

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Cup and handle/ double bottom normally a good thing i believe?...

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News